Literature DB >> 26064389

Tonsilectomy in sickle cell diseases.

Mehmet Rami Helvaci1, Cumali Gokce2, Ramazan Davran2, Can Acipayam3, Seckin Akkucuk4, Mustafa Ugur4.   

Abstract

BACKGROUND: We tried to understand whether or not there are lowered prevalences of terminal consequences of sickle cell diseases (SCDs) with tonsilectomy.
METHODS: All cases with SCDs were taken into the study.
RESULTS: The study included 334 patients (164 females). There were 27 cases with tonsilectomy and 307 cases without. The mean ages, female ratios, and prevalences of associated thalassemia minors and smoking were similar in both groups (P>0.05 for all). Although the white blood cell and platelet counts of peripheric blood were higher in patients without tonsilectomy, the mean hematocrit value was lower in them, but the differences were nonsignificant probably due to the small sample size of the tonsilectomy group (P>0.05 for all). Similarly, although the painful crises per year, digital clubbing, leg ulcers, pulmonary hypertension, chronic obstructive pulmonary disease, rheumatic heart disease, avascular necrosis of bone, cirrhosis, stroke, and mortality were higher in cases without tonsilectomy, the differences were nonsignificant probably due to the same reason again (P>0.05 for all).
CONCLUSION: There may be an inverse relationship between prevalence of tonsilectomy and severity of SCDs, and the tonsils may act as chronic inflammatory foci accelerating the chronic endothelial damage all over the body in such patients.

Entities:  

Keywords:  Sickle cell diseases; atherosclerosis; chronic endothelial damage; tonsillectomy

Year:  2015        PMID: 26064389      PMCID: PMC4443223     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  19 in total

1.  Prediction of adverse outcomes in children with sickle cell disease.

Authors:  S T Miller; L A Sleeper; C H Pegelow; L E Enos; W C Wang; S J Weiner; D L Wethers; J Smith; T R Kinney
Journal:  N Engl J Med       Date:  2000-01-13       Impact factor: 91.245

2.  Personal experience.

Authors:  L Schamroth
Journal:  S Afr Med J       Date:  1976-02-28

Review 3.  Mechanism of action of hydroxyurea in the management of sickle cell anemia in adults.

Authors:  S Charache
Journal:  Semin Hematol       Date:  1997-07       Impact factor: 3.851

4.  Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension.

Authors:  Micah R Fisher; Paul R Forfia; Elzbieta Chamera; Traci Housten-Harris; Hunter C Champion; Reda E Girgis; Mary C Corretti; Paul M Hassoun
Journal:  Am J Respir Crit Care Med       Date:  2009-01-22       Impact factor: 21.405

Review 5.  The metabolic syndrome.

Authors:  Robert H Eckel; Scott M Grundy; Paul Z Zimmet
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

6.  Is pain crisis a cause of death in sickle cell disease?

Authors:  N A Parfrey; W Moore; G M Hutchins
Journal:  Am J Clin Pathol       Date:  1985-08       Impact factor: 2.493

Review 7.  Pathophysiology and treatment of stroke in sickle-cell disease: present and future.

Authors:  Jeffrey A Switzer; David C Hess; Fenwick T Nichols; Robert J Adams
Journal:  Lancet Neurol       Date:  2006-06       Impact factor: 44.182

8.  Metformin and parameters of physical health.

Authors:  Mehmet Rami Helvaci; Hasan Kaya; Ali Borazan; Cahit Ozer; Mahmut Seyhanli; Atilla Yalcin
Journal:  Intern Med       Date:  2008-04-16       Impact factor: 1.271

9.  Prevalence, aetiologies and significance of clubbing in a department of general internal medicine.

Authors:  X Vandemergel; B Renneboog
Journal:  Eur J Intern Med       Date:  2008-02-11       Impact factor: 4.487

10.  Gender differences in severity of sickle cell diseases in non-smokers.

Authors:  Mehmet Rami Helvaci; Orhan Ayyildiz; Mehmet Gundogdu
Journal:  Pak J Med Sci       Date:  2013-07       Impact factor: 1.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.